Target intelligence / Profile preview

FRY antisense RNA 1 (FRY-AS1)

Target
FRY-AS1
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

FRY antisense RNA 1 (FRY-AS1) is a long non-coding RNA transcribed from the reverse strand of the FRY gene locus on chromosome 13. As an antisense RNA, it may function to regulate the expression of the FRY gene or neighboring genes by forming RNA-RNA duplexes, altering mRNA stability, or affecting chromatin and epigenetic states. Antisense RNAs are a class of regulatory molecules broadly involved in post-transcriptional gene regulation, genome organization, and epigenetic modification, but the specific targets and functions of FRY-AS1 are yet to be clearly defined in the literature. FRY-AS1 is best classified as a regulatory lncRNA (natural antisense transcript), not as a receptor, enzyme, transporter, or other typical drug target class. There is no evidence to suggest FRY-AS1 is a known therapeutic target or that it interacts directly with drugs, nor is it established as a disease biomarker. Its role is inferred based on the general functions of antisense RNAs in cellular gene regulation.

Other names
RP11-207N4.2
02

Mechanism of action

Not applicable; there are no drugs known to target FRY-AS1 directly.

03

Biological functions

Regulation of gene expression (as typical for antisense RNAs)RNA-RNA duplex formationPossible modulation of mRNA stability
04

Disease associations

No directly documented association with specific diseases; antisense RNAs in general can participate in pathways linked to cancer, neurodegeneration, imprinting disorders, etc., but specific roles for FRY-AS1 remain undocumented

Beyond the preview

Go deeper on FRY antisense RNA 1 (FRY-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FRY antisense RNA 1 (FRY-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call